0001415889-23-005666.txt : 20230331
0001415889-23-005666.hdr.sgml : 20230331
20230331162147
ACCESSION NUMBER: 0001415889-23-005666
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230329
FILED AS OF DATE: 20230331
DATE AS OF CHANGE: 20230331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Utter Christine Marie
CENTRAL INDEX KEY: 0001707685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 23788071
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-03312023_080336.xml
X0407
4
2023-03-29
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707685
Utter Christine Marie
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
false
true
false
false
SVP, FINANCE & CAO
1
Common Stock
2023-03-29
4
M
0
4688
40.45
A
42747
D
Common Stock
2023-03-29
4
S
0
3247
47.7980
D
39500
D
Common Stock
2023-03-29
4
S
0
1441
47.7752
D
38059
D
Stock Option (Right to Buy)
40.45
2023-03-29
4
M
0
4688
40.45
D
2024-09-23
Common Stock
4688
0
D
Stock Option (Right to Buy)
51
2025-01-02
Common Stock
17800
17800
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
4321
4321
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
371
371
D
Stock Option (Right to Buy)
51.16
2030-01-28
Common Stock
23800
23800
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
50750
50750
D
Stock Option (Right to Buy)
38.10
2032-01-06
Common Stock
43500
43500
D
Stock Option (Right to Buy)
39.42
2033-01-04
Common Stock
32500
32500
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
Represents an option award of 33,250 options and an option award of 17,500 options. These option awards were each granted on January 6, 2021, and each vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-03-31